论文部分内容阅读
目的探讨瑞格列奈分散片与阿卡波糖片联合治疗社区老年糖尿病的临床应用效果。方法 60例社区老年糖尿病患者,随机分为观察组与对照组,各30例。观察组采用瑞格列奈分散片与阿卡波糖片联合治疗,对照组只采用阿卡波糖片进行治疗。对比两组患者的治疗效果。结果观察组治疗总有效率为96.67%,高于对照组的80.00%,差异具有统计学意义(P<0.05)。治疗前,两组患者空腹血糖、餐后2 h血糖浓度对比,差异均无统计学意义(P>0.05);治疗后,两组患者空腹血糖、餐后2 h血糖浓度均较本组治疗前降低,且观察组降低程度优于对照组,差异均具有统计学意义(P<0.05)。结论瑞格列奈分散片与阿卡波糖片联合治疗社区老年糖尿病临床应用效果显著,有效率较高。
Objective To investigate the clinical effects of repaglinide dispersible tablets and acarbose in the treatment of elderly patients with diabetes mellitus. Methods 60 elderly patients with diabetes mellitus were randomly divided into observation group and control group, with 30 cases in each group. The observation group was treated with repaglinide dispersible tablets and acarbose, while the control group was treated with acarbose alone. Compare the treatment effect of two groups of patients. Results The total effective rate of the observation group was 96.67%, which was higher than that of the control group (80.00%), the difference was statistically significant (P <0.05). Before treatment, there was no significant difference in fasting blood glucose and postprandial blood glucose at 2 h between the two groups (P> 0.05). After treatment, fasting blood glucose and postprandial blood glucose at 2 h were significantly higher than those before treatment Decreased, and the observation group was better than the control group, the differences were statistically significant (P <0.05). Conclusion The combination of repaglinide dispersible tablets and acarbose in elderly patients with diabetes mellitus is effective and effective.